Helix Biopharma Corp Stock Price History
| HBP Stock | CAD 0.77 0.07 10.00% |
Below is the normalized historical share price chart for Helix BioPharma Corp extending back to June 03, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Helix BioPharma stands at 0.77, as last reported on the 23rd of November, with the highest price reaching 0.77 and the lowest price hitting 0.75 during the day.
If you're considering investing in Helix Stock, it is important to understand the factors that can impact its price. Helix BioPharma Corp holds Efficiency (Sharpe) Ratio of -0.0403, which attests that the entity had a -0.0403% return per unit of risk over the last 3 months. Helix BioPharma Corp exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Helix BioPharma's Market Risk Adjusted Performance of 0.1498, standard deviation of 8.05, and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide.
At this time, Helix BioPharma's Common Stock Shares Outstanding is very stable compared to the past year. As of the 23rd of November 2024, Other Stockholder Equity is likely to grow to about 44.3 M, though Total Stockholder Equity is likely to grow to (85.5 K). . At this time, Helix BioPharma's Price To Sales Ratio is very stable compared to the past year. As of the 23rd of November 2024, Price Sales Ratio is likely to grow to 20.62, while Price Earnings Ratio is likely to drop (5.80). Helix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.0591 | 50 Day MA 1.007 | Beta (0.84) |
Helix |
Sharpe Ratio = -0.0403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HBP |
Estimated Market Risk
| 8.12 actual daily | 72 72% of assets are less volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Helix BioPharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Helix BioPharma by adding Helix BioPharma to a well-diversified portfolio.
Price Book 77.464 | Book Value (0) | Enterprise Value 36.7 M | Enterprise Value Ebitda (6.36) | Shares Float 44 M |
Helix BioPharma Stock Price History Chart
There are several ways to analyze Helix Stock price data. The simplest method is using a basic Helix candlestick price chart, which shows Helix BioPharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 16, 2024 | 1.34 |
| Lowest Price | November 6, 2024 | 0.57 |
Helix BioPharma November 23, 2024 Stock Price Synopsis
Various analyses of Helix BioPharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Helix Stock. It can be used to describe the percentage change in the price of Helix BioPharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Helix Stock.| Helix BioPharma Price Rate Of Daily Change | 1.10 | |
| Helix BioPharma Price Daily Balance Of Power | 3.50 | |
| Helix BioPharma Price Action Indicator | 0.05 |
Helix BioPharma November 23, 2024 Stock Price Analysis
Helix Stock Price History Data
The price series of Helix BioPharma for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 0.77 with a coefficient of variation of 21.08. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.06. The median price for the last 90 days is 1.15. The company completed 1:5 stock split on 16th of August 2024.| Open | High | Low | Close | Volume | ||
11/23/2024 | 0.75 | 0.77 | 0.75 | 0.77 | ||
| 11/22/2024 | 0.75 | 0.77 | 0.75 | 0.77 | 7,560 | |
| 11/21/2024 | 0.67 | 0.70 | 0.67 | 0.70 | 3,100 | |
| 11/20/2024 | 0.73 | 0.73 | 0.57 | 0.70 | 17,500 | |
| 11/19/2024 | 0.74 | 0.74 | 0.71 | 0.71 | 1,500 | |
| 11/18/2024 | 0.68 | 0.70 | 0.68 | 0.70 | 13,000 | |
| 11/15/2024 | 0.68 | 0.68 | 0.68 | 0.68 | 100,750 | |
| 11/14/2024 | 0.70 | 0.70 | 0.65 | 0.68 | 102,026 | |
| 11/13/2024 | 0.64 | 0.67 | 0.63 | 0.67 | 3,668 | |
| 11/12/2024 | 0.75 | 0.78 | 0.66 | 0.70 | 33,544 | |
| 11/11/2024 | 0.73 | 0.73 | 0.73 | 0.73 | 500.00 | |
| 11/08/2024 | 0.80 | 0.80 | 0.75 | 0.75 | 7,760 | |
| 11/07/2024 | 0.60 | 0.80 | 0.60 | 0.80 | 10,800 | |
| 11/06/2024 | 0.69 | 0.69 | 0.50 | 0.57 | 50,269 | |
| 11/05/2024 | 0.75 | 0.75 | 0.71 | 0.71 | 3,250 | |
| 11/04/2024 | 0.76 | 0.76 | 0.76 | 0.76 | 525.00 | |
| 11/01/2024 | 0.79 | 0.79 | 0.78 | 0.78 | 1,900 | |
| 10/31/2024 | 0.86 | 0.86 | 0.76 | 0.82 | 9,526 | |
| 10/30/2024 | 0.90 | 0.90 | 0.90 | 0.90 | 1.00 | |
| 10/29/2024 | 0.90 | 0.94 | 0.83 | 0.90 | 21,665 | |
| 10/28/2024 | 1.05 | 1.05 | 0.92 | 1.01 | 13,256 | |
| 10/25/2024 | 1.13 | 1.13 | 1.00 | 1.00 | 16,416 | |
| 10/24/2024 | 1.10 | 1.13 | 1.10 | 1.13 | 200.00 | |
| 10/23/2024 | 1.00 | 1.09 | 0.97 | 1.09 | 44,373 | |
| 10/22/2024 | 1.33 | 1.33 | 1.17 | 1.17 | 4,263 | |
| 10/21/2024 | 1.13 | 1.13 | 0.92 | 1.07 | 11,970 | |
| 10/18/2024 | 1.20 | 1.20 | 1.05 | 1.13 | 1,295 | |
| 10/17/2024 | 1.33 | 1.33 | 1.20 | 1.23 | 1,500 | |
| 10/16/2024 | 1.29 | 1.34 | 1.26 | 1.34 | 9,000 | |
| 10/15/2024 | 1.16 | 1.29 | 1.16 | 1.26 | 7,303 | |
| 10/11/2024 | 0.93 | 1.24 | 0.93 | 1.24 | 8,763 | |
| 10/10/2024 | 1.01 | 1.01 | 1.00 | 1.00 | 1,700 | |
| 10/09/2024 | 1.14 | 1.14 | 1.08 | 1.08 | 400.00 | |
| 10/08/2024 | 1.17 | 1.17 | 0.95 | 1.01 | 2,150 | |
| 10/07/2024 | 1.19 | 1.19 | 1.13 | 1.13 | 401.00 | |
| 10/04/2024 | 1.17 | 1.17 | 1.17 | 1.17 | 262.00 | |
| 10/03/2024 | 1.14 | 1.14 | 1.14 | 1.14 | 300.00 | |
| 10/02/2024 | 1.11 | 1.19 | 1.11 | 1.19 | 2,500 | |
| 10/01/2024 | 1.19 | 1.19 | 1.11 | 1.11 | 200.00 | |
| 09/30/2024 | 1.18 | 1.19 | 1.18 | 1.19 | 934.00 | |
| 09/27/2024 | 1.06 | 1.19 | 1.06 | 1.17 | 1,450 | |
| 09/26/2024 | 1.19 | 1.19 | 1.19 | 1.19 | 1,024 | |
| 09/25/2024 | 1.19 | 1.19 | 1.19 | 1.19 | 2,000 | |
| 09/24/2024 | 1.20 | 1.20 | 1.19 | 1.19 | 2,800 | |
| 09/23/2024 | 1.05 | 1.23 | 1.05 | 1.19 | 3,533 | |
| 09/20/2024 | 1.23 | 1.29 | 1.18 | 1.26 | 7,504 | |
| 09/19/2024 | 1.29 | 1.29 | 1.29 | 1.29 | 100.00 | |
| 09/18/2024 | 1.32 | 1.32 | 1.26 | 1.26 | 200.00 | |
| 09/17/2024 | 1.32 | 1.32 | 1.32 | 1.32 | 1.00 | |
| 09/16/2024 | 1.32 | 1.32 | 1.32 | 1.32 | 100.00 | |
| 09/13/2024 | 1.25 | 1.25 | 1.25 | 1.25 | 1.00 | |
| 09/12/2024 | 1.32 | 1.32 | 1.25 | 1.25 | 200.00 | |
| 09/11/2024 | 1.32 | 1.32 | 1.32 | 1.32 | 13,300 | |
| 09/10/2024 | 1.29 | 1.30 | 1.28 | 1.30 | 2,500 | |
| 09/09/2024 | 1.21 | 1.22 | 1.15 | 1.22 | 3,200 | |
| 09/06/2024 | 1.30 | 1.30 | 1.30 | 1.30 | 1.00 | |
| 09/05/2024 | 1.29 | 1.30 | 1.10 | 1.30 | 61,197 | |
| 09/04/2024 | 1.24 | 1.29 | 1.24 | 1.29 | 521.00 | |
| 09/03/2024 | 1.26 | 1.26 | 1.26 | 1.26 | 2,100 | |
| 08/30/2024 | 1.20 | 1.26 | 1.20 | 1.26 | 724.00 | |
| 08/29/2024 | 1.15 | 1.20 | 1.15 | 1.20 | 300.00 |
About Helix BioPharma Stock history
Helix BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Helix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Helix BioPharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Helix BioPharma stock prices may prove useful in developing a viable investing in Helix BioPharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 49 M | 96.5 M | |
| Net Loss | -7.2 M | -7.6 M |
Helix BioPharma Stock Technical Analysis
Helix BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Helix BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Helix BioPharma's price direction in advance. Along with the technical and fundamental analysis of Helix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Helix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (1.52) | |||
| Treynor Ratio | 0.1398 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Helix Stock
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.